1. Home
  2. MIRA vs REED Comparison

MIRA vs REED Comparison

Compare MIRA & REED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MIRA Pharmaceuticals Inc.

MIRA

MIRA Pharmaceuticals Inc.

HOLD

Current Price

$1.02

Market Cap

43.7M

Sector

Health Care

ML Signal

HOLD

REED

Reed's Inc.

N/A

Current Price

$2.43

Market Cap

42.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
MIRA
REED
Founded
2020
1987
Country
United States
United States
Employees
N/A
44
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.7M
42.8M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
MIRA
REED
Price
$1.02
$2.43
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
128.2K
10.9K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$18.74
Revenue Next Year
N/A
$18.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.90
$1.75
52 Week High
$2.45
$5.97

Technical Indicators

Market Signals
Indicator
MIRA
REED
Relative Strength Index (RSI) 46.60 27.85
Support Level $0.99 $1.92
Resistance Level $1.24 $2.67
Average True Range (ATR) 0.04 0.47
MACD -0.00 -0.15
Stochastic Oscillator 26.83 1.99

Price Performance

Historical Comparison
MIRA
REED

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

About REED Reed's Inc.

Reed's Inc is a branded beverage company offering a portfolio of natural, premium, and functional beverages under the Reed's and Virgil's brands. The company's portfolio of handcrafted, all-natural beverages is sold in outlets nationwide, including the natural and specialty food channel, grocery stores, mass merchants, drug stores, convenience stores, club stores, and on-premise locations, including bars and restaurants. The company operates in a single reportable segment, which consists of manufacturing carbonated beverages under Reed's and Virgil's brand names.

Share on Social Networks: